Source: Medicines Authority (MT) Revision Year: 2021 Publisher: AGEPHA Pharma s.r.o, Diaľničná cesta 5, Senec, 903 01, Slovakia
Xorox 30 mg/g eye ointment is indicated for the treatment of herpes simplex keratitis.
Unless otherwise prescribed, a 1cm ribbon of ointment should be placed inside the lower conjunctival sac five times a day (at approximately 4 hourly intervals). The treatment should continue for at least 3 days after the healing is complete.
As for adults
No adjustment in dosage is required.
No adjustment in dosage is required.
Ocular use.
No case of overdose has been reported. Even if the entire content of a 4.5 g tube of Xorox eye ointment, containing 135 mg aciclovir, is swallowed, no undesirable effects would be expected.
5 years.
Chemical and physical in-use stability has been demonstrated for 30 days at 25°C.
From a microbiological point of view, once opened, the product may be stored for a maximum of 28 days at 25°C. Other in-use storage times and conditions are the responsibility of the user.
Store below 25°C.
White aluminium tube with internal epoxy phenol lacquer and white, HDPE cannula and cap containing 4.5 g ointment.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
